S&P 500

5.744,72

-0,01%

Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

Cadastre-se

Início
Investir
Ações
EUA
NASDAQ
Hoth Therapeutics Inc (HOTH)
Hoth Therapeutics Inc (HOTH) Notícias

HOTH

Hoth Therapeutics (HOTH)

Hoth Therapeutics Inc

De:

Notícias regulamentadas

Procure um Texto:

Ordenação:

Notícias não regulamentadas

Apresentando as notícias mais relevantes sobre:NASDAQ:HOTH

1 2 3 4 5 6 7 8 9 Próxima >>

Data	Hora	Fonte	Título	Código	Companhia
17/09/2024	08:57	PR Newswire (US)	Hoth Therapeutics Announces Promising Preclinical Results for Alzheimer's Drug HT-ALZ	NASDAQ:HOTH	Hoth Therapeutics Inc
05/09/2024	11:32	PR Newswire (US)	Hoth Therapeutics Announces Expansion of Clinical Sites for HT-001 Phase 2a Trial	NASDAQ:HOTH	Hoth Therapeutics Inc
05/09/2024	09:03	PR Newswire (US)	Hoth Therapeutics Announces Positive Data from First-of-its-Kind Human Patient Treatment of EGFRI-Associated Skin Toxicities with HT-001	NASDAQ:HOTH	Hoth Therapeutics Inc
21/08/2024	17:15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:HOTH	Hoth Therapeutics Inc
16/08/2024	17:15	Edgar (US Regulatory)	Form S-8 - Securities to be offered to employees in employee benefit plans	NASDAQ:HOTH	Hoth Therapeutics Inc
15/08/2024	09:04	PR Newswire (US)	Hoth Therapeutics and Aronnax Inc. Enter Master Services Agreement For HT-KIT Cancer Therapeutic	NASDAQ:HOTH	Hoth Therapeutics Inc
09/08/2024	17:05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:HOTH	Hoth Therapeutics Inc
07/08/2024	17:15	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:HOTH	Hoth Therapeutics Inc
24/07/2024	11:30	AllPennyStocks.com	Micro Cap Already Off To The Races At The Bell	NASDAQ:HOTH	Hoth Therapeutics Inc
24/07/2024	07:30	PR Newswire (US)	Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment	NASDAQ:HOTH	Hoth Therapeutics Inc
16/07/2024	09:31	PR Newswire (US)	Hoth Therapeutics Expands Clinical Trial for Cancer Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
18/06/2024	07:15	Edgar (US Regulatory)	Form ARS - Annual Report to Security Holders	NASDAQ:HOTH	Hoth Therapeutics Inc
18/06/2024	07:10	Edgar (US Regulatory)	Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material	NASDAQ:HOTH	Hoth Therapeutics Inc
18/06/2024	07:07	Edgar (US Regulatory)	Form DEF 14A - Other definitive proxy statements	NASDAQ:HOTH	Hoth Therapeutics Inc
10/06/2024	09:11	PR Newswire (US)	Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery	NASDAQ:HOTH	Hoth Therapeutics Inc
01/05/2024	09:00	PR Newswire (US)	Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024	NASDAQ:HOTH	Hoth Therapeutics Inc
27/03/2024	15:00	PR Newswire (US)	Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds	NASDAQ:HOTH	Hoth Therapeutics Inc
27/03/2024	09:27	PR Newswire (US)	Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment	NASDAQ:HOTH	Hoth Therapeutics Inc
19/03/2024	09:21	PR Newswire (US)	Hoth Therapeutics Announces Positive Data In Completed Study of Alzheimer's Disease Pre-Clinical Treatment with HT-ALZ	NASDAQ:HOTH	Hoth Therapeutics Inc
29/02/2024	10:38	PR Newswire (US)	Hoth Therapeutics Retains Venable LLP to Expand Its Patent Portfolio	NASDAQ:HOTH	Hoth Therapeutics Inc
26/02/2024	10:11	PR Newswire (US)	Hoth Therapeutics Engages Altasciences to Perform Key Study for HT-KIT Cancer Fighting Therapeutic	NASDAQ:HOTH	Hoth Therapeutics Inc
13/02/2024	13:45	PR Newswire (US)	Hoth Therapeutics to Attend BIO CEO and Investor Conference, February 26-27, 2024	NASDAQ:HOTH	Hoth Therapeutics Inc
18/01/2024	10:20	PR Newswire (US)	Hoth Therapeutics Announces it Received FDA Approval to Expand HT-001 Clinical Trial to Treat Severely Ill Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
27/12/2023	10:21	PR Newswire (US)	Hoth Therapeutics Announces Expansion of FDA Cleared First-In-Human Clinical Trial For Cancer Patients of HT-001 at University of Miami	NASDAQ:HOTH	Hoth Therapeutics Inc
05/12/2023	10:33	PR Newswire (US)	Hoth Therapeutics Announces it Has Successfully Completed Manufacturing of its Cancer fighting HT-KIT for IND-Enabling Studies	NASDAQ:HOTH	Hoth Therapeutics Inc
14/11/2023	10:37	PR Newswire (US)	Hoth Therapeutics Announces Successful Completion of Pre-IND Meeting with FDA Regarding Development of Hoth's Cancer Fighting HT-KIT	NASDAQ:HOTH	Hoth Therapeutics Inc
10/11/2023	10:00	PR Newswire (US)	Hoth Therapeutics to Present at NobleCon's 19th Annual Emerging Growth Investor Conference, December 3-5, 2023	NASDAQ:HOTH	Hoth Therapeutics Inc
05/10/2023	11:03	PR Newswire (US)	Hoth Therapeutics Announces Merveille.ai Artificial intelligence Initiative for Drug Discovery	NASDAQ:HOTH	Hoth Therapeutics Inc
02/10/2023	09:33	PR Newswire (US)	FDA Grants Hoth Therapeutics Pre-IND Meeting for HT-KIT, Treatment for Cancer Patients	NASDAQ:HOTH	Hoth Therapeutics Inc
15/09/2023	15:38	PR Newswire (US)	Hoth Therapeutics Announces Closing of $2.89 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules	NASDAQ:HOTH	Hoth Therapeutics Inc